Trials / Completed
CompletedNCT06163053
A Study to Evaluate Satisfaction With Care in Patients With Cancer Receiving Immunotherapy Treatment at Home
A French Non-interventional Prospective Multicenter Study Evaluating Quality of Care Perception of Cancer Patients Treated by Immunotherapy at Home - SATISFACT-HOME
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 49 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this observational study in France is to evaluate changes in satisfaction with care in participants with solid tumors who transitioned from receiving immunotherapy treatment in the hospital outpatient setting to receiving treatment at home
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Immunotherapy | Immune checkpoint inhibitors in approved indications |
Timeline
- Start date
- 2023-08-29
- Primary completion
- 2025-06-12
- Completion
- 2025-06-12
- First posted
- 2023-12-08
- Last updated
- 2026-01-14
Locations
3 sites across 1 country: France
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT06163053. Inclusion in this directory is not an endorsement.